### 4. Linear Models

* interpreting sparse linear models

* application to case study

* interpretation challenges

---

### Parsimony

---

### Simulatability

---

### Modularity

---

### Global & local interpretations

---

### Case study formulation

---

### Data preparation

---

### Evaluation criteria

---

### Model fitting

---

### Evaluation results

---

### Coefficient paths

---

### Interpretation

---

### Model checks

---

### Final conclusions

---

### Possible Improvements

---

- Are there distinct gene pathway signatures for different drugs?

- In this case, we should consider either drug-pathway interaction terms or drug-specific classifiers.

---

### Instability

---

### Simulation setup

---

### Simulation results

---

### Takeaway

---

### Interpretability vs. accuracy trade-offs

(common story -> connection to linear models)

---

### Interpretability vs. accuracy trade-offs

(perhaps linear models are competitive)

---

### Interpretability vs. accuracy trade-offs

(example story with CZ benchmarking)

---